Radiation environment in high-altitude Antarctic plateau: Recent measurements and model studies.

Antarctica Cosmic rays Ground-level enhancement High altitudes Liulin dosimeter Natural radiation background Passive detectors Personnel dosimetry

Journal

The Science of the total environment
ISSN: 1879-1026
Titre abrégé: Sci Total Environ
Pays: Netherlands
ID NLM: 0330500

Informations de publication

Date de publication:
10 Sep 2023
Historique:
received: 17 03 2023
revised: 03 05 2023
accepted: 16 05 2023
medline: 26 5 2023
pubmed: 26 5 2023
entrez: 25 5 2023
Statut: ppublish

Résumé

Polar regions are the most exposed to secondary particles and radiation produced by primary cosmic rays in the atmosphere, because naturally they are with marginal geomagnetic shielding. In addition, the secondary particle flux contributing to the complex radiation field is enhanced at high-mountain altitudes compared to sea level because of the reduced atmospheric attenuation. At present, there are very few systematic experimental measurements of environmental dose at high southern latitudes, specifically at high-altitude region. Here, we report a campaign of measurements with different devices, that is passive and Liulin-type dosimeters, of the radiation background at high-mountain Antarctic station Vostok (3488 m above sea level, 78° 27' S; 106° 50' E). We compare the measurements with a Monte Carlo-based model for the propagation of the cosmic rays through the atmosphere and assessment of the radiation field in the atmosphere. We employed the model to estimate the radiation dose at Vostok station during the ground-level enhancement at 28 October 2021. As in previous studies by other teams, we show that the annual dose equivalent at high-altitude Antarctic facilities can significantly exceed the limit of 1 mSv established for the general population by the ICRP.

Identifiants

pubmed: 37230348
pii: S0048-9697(23)02925-X
doi: 10.1016/j.scitotenv.2023.164304
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

164304

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no conflicts of interest.

Auteurs

A L Mishev (AL)

Space Physics and Astronomy Research Unit, University of Oulu, Finland; Sodankylä Geophysical Observatory, University of Oulu, Finland. Electronic address: alexander.mishev@oulu.fi.

S Kodaira (S)

Radiation Measurement Research Group, National Institutes for Quantum Science and Technology, 4-9-1 Anagawa, Inage, Chiba 263-8555, Japan.

H Kitamura (H)

Radiation Measurement Research Group, National Institutes for Quantum Science and Technology, 4-9-1 Anagawa, Inage, Chiba 263-8555, Japan.

O Ploc (O)

Nuclear Physics Institute of the Czech Academy of Sciences, Hlavní 130, Řež 250 68, Czech Republic.

I Ambrožová (I)

Nuclear Physics Institute of the Czech Academy of Sciences, Hlavní 130, Řež 250 68, Czech Republic.

R V Tolochek (RV)

Institute of Biomedical Problems of the Russian Academy of Sciences (IBMP RAS), 76A Khoroshevskoye shosse, Moscow 123007, Russian Federation; P.N.Lebedev Physical Institute of the Russian Academy of Sciences (LPI RAS), 53 Leninskiy Prospekt, Moscow 119991, Russian Federation.

I S Kartsev (IS)

Institute of Biomedical Problems of the Russian Academy of Sciences (IBMP RAS), 76A Khoroshevskoye shosse, Moscow 123007, Russian Federation; LLC "SNIIP-Plus", 5(1) Raspletina, Moscow 123060, Russian Federation.

V A Shurshakov (VA)

Institute of Biomedical Problems of the Russian Academy of Sciences (IBMP RAS), 76A Khoroshevskoye shosse, Moscow 123007, Russian Federation.

A A Artamonov (AA)

Institute of Biomedical Problems of the Russian Academy of Sciences (IBMP RAS), 76A Khoroshevskoye shosse, Moscow 123007, Russian Federation.

K O Inozemtsev (KO)

Institute of Biomedical Problems of the Russian Academy of Sciences (IBMP RAS), 76A Khoroshevskoye shosse, Moscow 123007, Russian Federation.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH